Championing Access to Care

By Rob Banaszak on August 9, 2011 in Access2Care, President's Message

We did it!  We met our Social Innovation Fund  (SIF) required match!

Truth be told, our funding partners and champions did it!  Twelve incredibly generous and committed corporations, foundations and individual investors ensured that we met our federal 1:1 match, and to date have committed more than $2.5 million dollars to AIDS United’s Access to Care (A2C) program, which is helping thousands of people living with HIV/AIDS receive the life-saving medical care and social support services they need and deserve.

I want to acknowledge the following visionaries for their commitment and dedication to improving the lives of those living with and at risk for HIV, and for their unwavering focus on ending the HIV/AIDS epidemic in America and indeed throughout the world.

  • Bristol Myers-Squibb
  • Broadway Cares/Equity Fights AIDS
  • Chevron
  • Elton John AIDS Foundation
  • Ford Foundation
  • Fred Eychaner
  • Gilead
  • Janssen
  • MAC AIDS Fund
  • Rogers Innovation Fund
  • ViiV Healthcare
  • Walgreen’s

Without these champions, AIDS United and our 10 amazing A2C grantees would not be able to deliver innovative programs that improve individual health outcomes and strengthen local services systems, connecting economically and socially marginalized individuals with HIV to high-quality, patient-centered health care.  For more information about SIF and the game-changing efforts of our A2C grantees, click here.

And now we need you to be our champion, so that we can take Access to Care to a higher level. By joining our investors and making a donation to AIDS United, you can make these initial investments grow – so that we can do more good.  Together we can create innovative, sustainable and scalable programs that improve the lives of people with HIV and that lead us to our ultimate goal – the end of the AIDS epidemic in America.

Thanks for the inspiration.

Mark

Post a Comment

We'd love to hear what you think about this piece! Submit your comments below and join the discussion.

< Back to the blog